News Releases

August 25, 2021
Bioventus Invests in Trice Medical Minimally Invasive Technologies
Bioventus Also Agrees to OUS Distribution and Co-Development Relationships DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a strategic investment in Trice Medical , Inc., a
Read More
July 14, 2021
Bioventus Appoints Mary Kay Ladone to Board of Directors
DURHAM, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of Mary Kay Ladone to the Company’s Board of Directors, effective July 15, 2021.
Read More
July 13, 2021
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
DURHAM, N.C., July 13, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, is launching OSTEOAMP SELECT Flowable, a flowable allograft bone graft substitute solution developed for a variety of patient procedures
Read More
June 24, 2021
Bioventus Invests in Vaporox
Ultrasonic Technology to Heal Diabetic Foot Ulcers DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox , Inc., a developer of a highly
Read More
Displaying 71 - 80 of 123